Cell therapy innovation is accelerating, but microbial contamination remains a critical threat to workflow efficiency and clinical outcomes. Mycoplasma, often undetected by conventional microscopy-based cell monitoring methods, can compromise genomic stability and regulatory compliance. PCR-based detection addresses these issues, offering speed and accuracy aligned with advanced therapy medicinal product development needs.
Download this ebook to learn how PCR testing helps prevent and detect Mycoplasma contamination in routine and clinical-grade cell culture, supporting safe, fast, and compliant cell therapy testing.
